Vasculature News and Research

RSS
Good number of natural bypass vessels an 'insurance policy' against blockage

Good number of natural bypass vessels an 'insurance policy' against blockage

PMI's CAAS software integrated with Ziehm Imaging's mobile cardiovascular imaging solutions

PMI's CAAS software integrated with Ziehm Imaging's mobile cardiovascular imaging solutions

Data from three Phase II clinical trials of PS-targeting antibody to be presented at 2010 ASCO Annual Meeting

Data from three Phase II clinical trials of PS-targeting antibody to be presented at 2010 ASCO Annual Meeting

Vascular Insights wins CE Mark approval for ClariVein Occlusion Catheter

Vascular Insights wins CE Mark approval for ClariVein Occlusion Catheter

TriReme Medical receives FDA expanded clearance for GliderXtreme PTA balloon catheter

TriReme Medical receives FDA expanded clearance for GliderXtreme PTA balloon catheter

Anti-inflammatory drugs help block kidney destruction that occurs with hypertension: Researchers

Anti-inflammatory drugs help block kidney destruction that occurs with hypertension: Researchers

Acceleron Pharma commences Phase 2 clinical trial of ACE-031 protein therapeutic in DMD patients

Acceleron Pharma commences Phase 2 clinical trial of ACE-031 protein therapeutic in DMD patients

New data on salt-sensitive hypertension to be presented at ASH 2010 conference

New data on salt-sensitive hypertension to be presented at ASH 2010 conference

Novel clinical research approaches for rapidly identifying and preventing congenital cardiovascular defects

Novel clinical research approaches for rapidly identifying and preventing congenital cardiovascular defects

Positive results from initial clinical trial of ClariVein catheter

Positive results from initial clinical trial of ClariVein catheter

Researchers demonstrate role of HSP-90 in portal hypertension

Researchers demonstrate role of HSP-90 in portal hypertension

Study underscores potential for VBL Therapeutics VB-111 as broad-spectrum cancer therapy

Study underscores potential for VBL Therapeutics VB-111 as broad-spectrum cancer therapy

Endra Life Sciences launches Nexus 128 preclinical photoacoustic CT scanner

Endra Life Sciences launches Nexus 128 preclinical photoacoustic CT scanner

Researchers show iRGD peptide increases treatment efficacy against cancer

Researchers show iRGD peptide increases treatment efficacy against cancer

Combining antiangiogenic cancer therapy with oncolytic virotherapy leads to regression of tumors

Combining antiangiogenic cancer therapy with oncolytic virotherapy leads to regression of tumors

Juventas Therapeutics commences enrollment in Phase I trial of JVS-100 for treatment of Class III heart failure

Juventas Therapeutics commences enrollment in Phase I trial of JVS-100 for treatment of Class III heart failure

Lung transplant patients may one day benefit from synthetic peptide, researchers report

Lung transplant patients may one day benefit from synthetic peptide, researchers report

Two separate articles describing preclinical data of ACE-041 published

Two separate articles describing preclinical data of ACE-041 published

Tips offered in April 2010 issue of American Journal Of Pathology

Tips offered in April 2010 issue of American Journal Of Pathology

InnerPulse selects Dassault Systemes' Abaqus FEA software

InnerPulse selects Dassault Systemes' Abaqus FEA software

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.